Bactiguard Holding AB (publ) interim report for the third quarter.
The audiocast for investors, analysts, and media with CEO Christine Lind together with CFO Patrick Bach from 24 October is available here.
Investors
Q3: Bactiguard delivers positive EBITDA and initiates review of 2028 financial targets due to previously announced agreement termination
-
Revenue73.9 MSEK(49.5)
-
EBITDA9.9 MSEK(-9.5)
-
Cash flow8.3 MSEK(-35.0)
Annual and Sustainability Report 2023
The Bactiguard Technology
The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.
Purpose
To champion a healthier world by preventing infections.
Vision
To be the global standard of care for preventing medical device related infections.
Mission
To be the premier partner for leading MedTech companies, joining forces to redefine healthcare and improve health worldwide.
Core values
- Respect
- Trust
- Transparency
- Performance
Bactiguard is a purpose-driven company with a strong corporate culture, firmly anchored in four core values. The values are an integral part of Bactiguard’s purpose to champion a healthier world by preventing infections and a prerequisite to achieve our targets.
Bactiguard as an investment
The ambition is to become a profitable knowledge and specialist organization which is a prerequisite to deliver on our financial, strategic and sustainability targets.
-
08Jan 2025
Bactiguard presents at SEB Nordic Seminar 2025
-
06Feb 2025
Year-end report 1 January – 31 December 2024
-
17Apr 2025
Annual Report 2024
Media & Investor Relations
-
Nina Nornholm
Head of Corporate Communication & Investor Relations
+46 70 855 0356